Cogent Biosciences, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cogent Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Cogent Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $5.44M, a 80.7% increase year-over-year.
  • Cogent Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $17.6M, a 29.6% increase year-over-year.
  • Cogent Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $15.7M, a 107% increase from 2022.
  • Cogent Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $7.6M, a 132% increase from 2021.
  • Cogent Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $3.28M, a 55.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.7M +$8.12M +107% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $7.6M +$4.32M +132% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $3.28M -$4.11M -55.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $7.39M +$7.05M +2042% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $345K -$1.13M -76.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $1.47M +$813K +123% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $660K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.